Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. PTC Therapeutics Inc shares valued at $4,761 were purchased by Almstead Zheng Yang on Jan 08 ’25. At $44.50 per share, Almstead Zheng Yang acquired 107 shares.
Also, Golden Lee Scott purchased 1,198 shares, netting a total of over 53,311 in proceeds.
Before that, Almstead Neil Gregory had added 1,552 shares to its account. In a trade valued at $69,064, the Officer bought PTC Therapeutics Inc shares for $44.50 each.
As published in a research note from Morgan Stanley on December 13, 2024, PTC Therapeutics Inc [PTCT] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $67 from $45. Analysts at RBC Capital Mkts upgraded the stock from ‘”a Sector perform”‘ to ‘”an Outperform”‘ outlook in a report released in early December. Earlier on September 04, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PTCT stock.
Analyzing PTCT Stock Performance
During the last five days, there has been a drop of approximately -0.22%. Over the course of the year, PTC Therapeutics Inc shares have dropped approximately -0.22%. Shares of the company reached a 52-week high of $47.06 on 01/02/25 and a 52-week low of $43.50 on 01/08/25. A 50-day SMA is recorded $44.78, while a 200-day SMA reached $36.33. Nevertheless, trading volume fell to 0.62 million shares from 0.58 million shares the previous day.
Support And Resistance Levels for PTC Therapeutics Inc (PTCT)
According to the 24-hour chart, there is a support level at 43.94, which, if violated, would cause prices to drop to 42.83. In the upper region, resistance lies at 45.71. The next price resistance is at 46.37. RSI (Relative Strength Index) is 47.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.41, which suggests the price will decrease in the coming days. Percent R is at 66.04%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
